Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Adding Viscosity Modifiers in the Mixing Process – V 2.0

Posted on By

SOP for Adding Viscosity Modifiers in the Mixing Process – V 2.0

Procedure for Adding Viscosity Modifiers in the Mixing Process

Department Manufacturing/Production/Quality Assurance (QA)/Quality Control (QC)/Research and Development (R&D)
SOP No. SOP/Ointment/193
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define a systematic approach for adding viscosity modifiers in the mixing process of pharmaceutical ointments. Proper incorporation of viscosity modifiers ensures batch uniformity, stability, and optimal spreadability of the final product.

2. Scope

This SOP applies to all personnel involved in the preparation, addition, and quality control of viscosity modifiers in the Manufacturing, Production, Quality Assurance (QA), Quality Control (QC), and Research and Development (R&D) departments.

3. Responsibilities

  • Production Supervisor: Ensures adherence to viscosity modifier addition protocol.
  • Process Operator: Monitors and controls mixing conditions for proper dispersion.
  • QA Officer: Verifies the consistency of the batch after viscosity modification.
  • QC Analyst: Conducts viscosity and homogeneity tests.
  • Maintenance Engineer: Ensures mixing equipment operates within defined parameters.
See also  Ointments: SOP for Handling Emergency Stops in Machines - V 2.0

4. Accountability

The Production Manager is accountable for ensuring that all viscosity modifier addition procedures comply with GMP, FDA, ICH, WHO, and company policies.

5. Procedure

5.1 Selection of Viscosity Modifiers

  • Common viscosity modifiers used in ointment manufacturing include:
    • Carbomers
    • Hydroxyethyl cellulose (HEC)
    • Xanthan gum
    • Polyacrylic acid derivatives
    • Silica-based thickeners
  • Ensure that the
selected viscosity modifier is compatible with the formulation.
  • Document selection in the **Viscosity Modifier Selection Log (Annexure-1).**
  • 5.2 Preparation Before Addition

    • Ensure that all required ingredients and excipients are available and within specifications.
    • Verify the calibration of weighing balances and mixing equipment.
    • Adjust the mixing speed based on the viscosity modifier type.
    • Record pre-addition checks in the **Pre-Addition Checklist (Annexure-2).**

    5.3 Addition Process

    • Gradually introduce the viscosity modifier into the mixing tank.
    • Maintain an optimal **mixing speed between 100-300 RPM** to avoid clumping.
    • If required, pre-disperse the viscosity modifier in a suitable solvent before addition.
    • Ensure even dispersion by **mixing continuously for 15-30 minutes.**
    • Document addition parameters in the **Viscosity Modifier Addition Log (Annexure-3).**

    5.4 Quality Control Testing

    • Measure viscosity using a **Brookfield Viscometer or equivalent.**
    • Conduct **homogeneity tests** to confirm even distribution of the modifier.
    • Compare viscosity values against predetermined specifications.
    • Document all test results in the **Viscosity Testing Log (Annexure-4).**

    6. Abbreviations

    • GMP – Good Manufacturing Practices
    • QA – Quality Assurance
    • QC – Quality Control
    • ICH – International Council for Harmonisation
    • FDA – Food and Drug Administration

    7. Documents

    • Viscosity Modifier Selection Log (Annexure-1)
    • Pre-Addition Checklist (Annexure-2)
    • Viscosity Modifier Addition Log (Annexure-3)
    • Viscosity Testing Log (Annexure-4)

    8. References

    • ICH Q8 – Pharmaceutical Development Guidelines
    • FDA Guidance on Topical Formulation Processing
    • WHO Guidelines on Manufacturing Quality Control

    9. SOP Version

    Version 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Viscosity Modifier Selection Log

    Date Batch No. Modifier Used Quantity (g) QA Approval

    Annexure-2: Pre-Addition Checklist

    Date Batch No. Equipment Checked Materials Verified QA Approval

    Annexure-3: Viscosity Modifier Addition Log

    Date Batch No. Modifier Added Mixing Speed (RPM) QA Approval

    Annexure-4: Viscosity Testing Log

    Date Batch No. Viscosity (cP) Test Equipment QA Approval

    12. Revision History

    Revision Date Revision No. Details Reason Approved By
    02/02/2025 2.0 Expanded Viscosity Modifier Addition Guidelines Regulatory Compliance QA Head
    See also  Ointments: SOP for Developing Ointments for Specific Skin Conditions - V 2.0
    Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

    Post navigation

    Previous Post: Aerosol: SOP for Inspecting Aerosol Cans Before Packing – V 2.0
    Next Post: SOP for Handling and Storing Raw Materials in Open Shelving Systems – V 2.0

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version